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Abstract
Background: Reports of the etiology of bacteremia in children from Nigeria are sparse and have been confounded
by wide spread non-prescription antibiotic use and suboptimal laboratory culture techniques. We aimed to
determine causative agents and underlying predisposing conditions of bacteremia in Nigerian children using data
arising during the introduction of an automated blood culture system accessed by 7 hospitals and clinics in the
Abuja area.
Methods: Between September 2008 and November 2009, we enrolled children with clinically suspected
bacteremia at rural and urban clinical facilities in Abuja or within the Federal Capital Territory of Nigeria. Blood was
cultured using an automated system with antibiotic removing device. We documented clinical features in all
children and tested for prior antibiotic use in a random sample of sera from children from each site.
Results: 969 children aged 2 months-5 years were evaluated. Mean age was 21 ± 15.2 months. All children were
not systematically screened but there were 59 (6%) children with established diagnosis of sickle cell disease and 42
(4.3%) with HIV infection. Overall, 212 (20.7%) had a positive blood culture but in only 105 (10.8%) were these
considered to be clinically significant. Three agents, Staphylococcus aureus (20.9%), Salmonella typhi (20.9%) and
Acinetobacter (12.3%) accounted for over half of the positive cultures. Streptococcus pneumoniae and non-typhi
Salmonellae each accounted for 7.6%. Although not the leading cause of bacteremia, Streptococcus pneumoniae
was the single leading cause of all deaths that occurred during hospitalization and after hospital discharge.
Conclusion: S. typhi is a significant cause of vaccine-preventable morbidity while S. pneumoniae may be a leading
cause of mortality in this setting. This observation contrasts with reports from most other African countries where
non-typhi Salmonellae are predominant in young children. Expanded surveillance is required to confirm the
preliminary observations from this pilot study to inform implementation of appropriate public health control
measures.
Background
Sub Saharan Africa contributes significantly to the glo-
bal mortality of children aged less than 5 years with
mortality rates of 100-250 per 1000 [1]. It is now well
established that invasive bacteria disease is the leading
cause of childhood mortality in sub-Saharan Africa and
most of these infections are preventable by the use of
vaccines which are already licensed and in routine use
in most developed countries. Few health facilities in
Africa have the microbiologic laboratories with capacity
to identify invasive bacterial infection. Thus the clinical
importance of bacterial infections and associated mortal-
ity is often not recognized with most febrile illnesses
being attributed to malaria. Randomized controlled effi-
cacy trials in Gambia [2,3]. and South Africa [4] and
effectiveness studies in Malawi [5] uncovered substantial
disease burden from Haemophilus influenzae type b
(Hib) and Streptococcus pneumoniae, while population
based surveillance studies in Kenya have demonstrated
substantial disease caused by S. pneumonia [6]. While S.
pneumoniae has been identified as the leading cause of
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[7], Kenya [6], Mozambique [8], this was not the case in
Ghana [9] and Malawi [10] where non-typhi Salmonella
(NTS) predominated. Availability of national epidemio-
logic data will strengthen advocacy for the introduction
of relevant vaccines.
Although Nigeria is the most populated country in the
sub region and records high infant and under-5 mortal-
ity rates of 97 and 189 per 1000 respectively [11], data
on the etiologic agents of invasive bacteria disease in
children are sparse.
Primary health care system is poorly developed in the
country and chemists, pharmacies, private clinics and
hospitals are often the first port of call for parents/guar-
dians of children seeking care for their children. Over-
the-counter antibiotic use is very prevalent and this is
likely to impact the outcome of any studies aimed at the
determination of the causes of bacteria infection in chil-
dren. It is possible that this healthcare seeking behavior
may of itself modify the spectrum of prevalent bacteria
pathogens and also the spectrum of clinical disease pre-
sentation. Previous reports of causes of bacteremia from
different parts of Nigeria utilized conventional blood
culture techniques with the use of human blood for the
preparation of blood agar and suboptimal methods for
the detection of fastidious organisms like S.pneumoniae.
Limitations of this approach have been reviewed [12].
Against this background, we sought to introduce surveil-
lance blood cultures using an automated system, provid-
ing access to the facility from 7 hospitals and clinics in
the Abuja area. Using data arising from this pilot sur-
veillance, we report the commonly identified causes of
community-acquired bacteremia in children aged 2
months-5 years in an urban and semi-urban setting with
reference to vaccine-preventable diseases.
Methods
Ethics Approval
This study was approved by the Federal Capital Terri-
tory of Nigeria Ethics Committee, Zankli Medical Cen-
ter Ethics Committee, National Hospital Abuja Ethics
Committee, Keffi Medical Center Ethics Committee,
The Joint Gambia Government and MRC Ethics Com-
mittee, and Michigan State University Institutional
Review Board.
Setting
Nigeria is the most populated country in sub-Saharan
Africa with a population of almost 150 million [13].
Abuja is the capital city of Nigeria, located in the Fed-
eral Capital Territory (FCT) which is the geographical
centre of Nigeria. It has a land area of 8,000 square kilo-
meters. It is bounded on the north by Kaduna State, the
west by Niger State, the east and southeast by
Nassarawa State and the southwest by Kogi State. Abuja
is a “planned” city as it was mainly built in the 1980s
and officially became Nigeria’s capital in 1991, replacing
the previous capital in Lagos. In 2006 the population
was estimated at 1.7 million but may currently be about
5.7 million [13]. Abuja and the FCT have experienced a
huge population growth; it has been reported that some
areas around Abuja have been growing at an annual rate
of 20 - 30%. The rapid spread of squatter settlements
a n ds h a n t yt o w n si na n da r o u n dt h ec i t yl i m i t si s
believed to be an important contributor to this rapid
growth. The rainy season begins in April and ends in
October. Within this period there is a brief interlude of
harmattan, occasioned by the Northeast Trade Wind,
with the main features of dust haze, intensified coldness
and dryness. The annual total rainfall is in the range of
1,100 to 1,600 mm. The population is diverse, with
increasing representation from the major ethnic groups
of Hausa, Yoruba and Igbos following the development
of the FCT and relocation of the federal capital.
There is perennial malaria transmission, mostly due to
Plasmodium falciparum and HIV prevalence of 5.6%
among pregnant women attending antenatal clinics.
National Immunization Program
The national expanded program on immunization calen-
dar in Nigeria includes Bacillus Calmette Guerin vacci-
nation, oral polio vaccine (OPV) and Hepatitis B at
birth, OPV, diphtheria-tetanus whole cell pertussis
(DPT) and Hepatitis B at 6 weeks, OPV and DPT 10
and 14 weeks, Hepatitis B and Measles at 9 months and
Yellow Fever at between 9-12 months. National immu-
nization coverage varies across the country but in the
FCT has been about 85% for DTP3 [14]. Additional vac-
cines such as conjugate pneumococcal and Haemophilus
influenzae type b are available at a few private clinics.
In 2008, Michigan State University in collaboration
with the National Hospital Abuja established a research
project to determine the etiologic agents of community-
acquired bacteremic syndromes (sepsis, pneumonia,
meningitis and bacteremia) in young Nigerian children
aged 2 months -5 years. The enrollment sites for this
Community-acquired Bacteremic Syndrome (CABSYNC)
study include a number of hospitals within Abuja city
and other rural settlements on the outskirt of Abuja,
carefully selected to capture a mix of urban and rural
population within easy reach of the diagnostic labora-
tories in Abuja city. Together, these facilities have an
annual pediatric outpatient attendance of over 110,000
and 12,000 admissions and include the following;
a) The National Hospital, Abuja The National Hospi-
tal of Abuja was originally designed to cater to the
needs of women and children in Nigeria and the West
African sub-region, with a view to reducing morbidity
and mortality rates, and to carrying out extensive
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and children in Africa. Phase 1 of the Hospital presently
contains 200 beds, but the centre has facilities for a
future expansion to 500 beds. The pediatric department
admits about 90-100 patients per month and attends to
1300-1500 patients per month in the out-patient depart-
ment. The facility provides postgraduate training in
Pediatrics and has eight Attending Pediatricians and
twenty five resident doctors.
b) University of Abuja Teaching Hospital, Gwagwa-
lada This is a district general hospital which has just
recently been designated the teaching hospital for the
University of Abuja. The hospital has a 300 bed capacity
and serves a rural population from several villages and
settlements on the outskirt of Abuja, within the Federal
Capital Territory and also from the adjoining states.
There are currently three Attending Pediatricians with
14 residents and with its new status; the university is in
the process of employing more attending Pediatricians.
c) Nyanya District Hospital This is a small district hos-
pital located on the outskirts of Abuja and functions as
a primary health care center with limited in-patient
capacity. This facility is staffed by five generalist physi-
cians, supported by nurses and midwives. Patients are
generally referred to the National Hospital for specialist
care. The facility has minimal laboratory support for
urine microscopy and malaria blood films.
d) Zankli Medical Center Zankli Medical Center
(ZMC) is a private hospital based in Abuja. It has
approximately 150 members on staff, 45 beds for in-
patient admission, 17 full time doctors, including 9
consultants. In addition to the above there are four
independent specialist clinics: Dental, Dermatology,
Ophthalmology and ENT, which operate within the
hospital premises. Constant power and water supplies
are guaranteed by in-house generators to maintain 24-
hour electricity and a borehole as a source of water.
Communication is facilitated through broadband inter-
net access and a network system within the hospital
maintained by an in-house engineer. The Hospital is
approved by the National Postgraduate Medical College
as a tutelage centre for senior registrars in general
practice and has recently embarked on the develop-
ment of academic and research activities in collabora-
tion with the Federal Ministry of Health of Nigeria and
Liverpool School of Tropical Medicine, UK. The facility
provides care for over 30,000 pediatric outpatients
annually, with 1,255 admissions. The Research Labora-
tory has two senior laboratory scientists and ten other
laboratory scientists working in the routine laboratory.
The lab is equipped with two light microscopes, one
fluorescent microscope, a Bactec™ MGIT machine for
mycobacterial culture, and a Bactec™ 9050 for bacter-
ial culture.
e) Garki General Hospital Garki Hospital Abuja (GHA)
is a private public hospital established in 1988. The hos-
pital is located within less than 5 miles of the National
Hospital and carters for a mix of population consisting
of middle class and low socioeconomic class population
from the outskirt of Abuja city. The pediatric facility has
25 beds with 784 annual admissions and 13,716 outpati-
ents. It is staffed by one Attending Pediatrician and four
medical officers.
f) Maitama Hospital Maitama Hospital Abuja (MHA)
is a government run general hospital within Abuja city.
This facility provides care for middle class and low
socioeconomic class population and has a large clientele
from some of the new periubran settlements on the out-
skirt of Abuja. It is staffed by one attending pediatrician
and four medical officers.
g) Federal Medical Center Keffi This is a general hos-
pital which is owned by the Federal Government and
provides clinical services to the semi-urban population
of Keffi and several rural settlements. This facility is
staffed by one Attending Pediatrician and five medical
officers.
The laboratories for this surveillance are primarily
based at ZMC. This site was instrumental in supporting
the generation of preliminary data that led to the devel-
opment of this project. The Center for Disease Control
and Prevention, Atlanta provided logistic support for
setting up the study laboratories and also provided con-
trol bacteria strains.
Prior to the commencement of this study, two senior
Microbiology Scientists were identified for special train-
ing for study procedures and the operation of the Bactec
culture instrument. Training was provided at the Medi-
cal Research Council Laboratories in the Gambia and
upon return to Nigeria, these Technicians have contin-
ued to provide supervision and guidance for other
laboratory staff. Since commencement, we have pro-
cured an additional Bactec™ 9050 culture instrument
through a generous donation from Beckton Dickinson,
which is now placed at the National Hospital. All the
facilities are within 30-45 minutes drive to either of the
laboratories.
Participant enrolment
Following an initial period of sensitization and training
for medical officers and residents, blood culture bottles
and vacutainer sets were made available to the different
sites.
We restricted enrollment initially to just NHA and
ZMC and gradually expanded to include the peripheral
sites at Gwagwalada, Nyanya, Keffi Medical center and
subsequently, GHA and MHA. Not all eligible subjects
were approached for enrollment because of insufficient
manpower to commit specifically for this study at the
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much on the availability of existing medical and nursing
staff at the different locations for subject enrollment and
also for completion of the questionnaire. Some of the
sites are currently understaffed and this clearly retarded
our ability to enroll more subjects and to obtain addi-
tional specimens such as CSF from clinically suspected
cases of meningitis. Such detailed clinical evaluation is
currently not routine care at most of these facilities due
to lack of adequate diagnostic laboratory services or
affordability by caregivers.
Full scale enrolment commenced in November 2008
after formal training was provided to all laboratory per-
sonnel. Children who presented with fever or hypother-
m i aw e r ei d e n t i f i e db yat r i a g en u r s ea n dc o n s e n tf o r
participation was sought.
Children attending the out-patient clinics or emer-
gency units were triaged and evaluated for eligibility.
Informed consent was obtained from the parent or guar-
dian. A physician administered a detailed questionnaire
to obtain information on clinical history and physical
examination findings. Appropriate clinical specimens
were then obtained and these include 1-3 ml of blood
for culture using the vacutainer set after cleaning the
skin with alcohol swabs. The specimen was collected
directly into the Bactec™ culture bottle and promptly
delivered by the project driver to ZMC microbiology
laboratory within 4 hrs of collection.
Data Acquisition
The Biomedical Research and Informatics Core (BRIC),
Michigan State University provided support and supervi-
sion for data management of this study. BRIC is a data
management unit for MSU that is involved in nearly
100 active clinical research protocols. Primary research
informatics support is provided by a locally developed
database application known as RIX.
Metadata design and entry
For the CABSYNC study data was collected from several
diverse sources. Forms were entered during the medical
exam, at the laboratory after tests specimen processing,
and at the time of follow-up. In order to streamline data
entry medical examinations forms were acquired from
the National Hospital in Abuja (NHA) and laboratory
forms from Zankli Medical Center. Next, online forms
were designed for RIX to closely mimic the actual forms
used onsite. This helped ensure that physicians and
laboratory technicians would not have to deviate much
from their normal workflow to enter study forms. Data
collection instruments that are used for online data cap-
ture tools are designed differently as compared to paper
forms. CABSYNC forms were edited to reduce rates of
implicit uncertain responses.
Training
The onsite staff in Abuja had to attend an online semi-
nar conducted by the Human Research Protection Pro-
gram at Michigan State University. This seminar is
required for anyone who is given credentials to the RIX
system. Additionally, the onsite staff needed to be
trained to properly use the RIX system. We used Skype
for communicating across borders.
Training sessions included: RIX training for data
entry, training for specimen tracking, barcode printing,
and printer maintenance and methods of subject track-
ing and data integrity checks.
Data Cleaning and analysis
RIX is capable of adding many restrictions to data entry
fields but for some variables these fields were left
unrestricted. For this pilot stage of data collection it was
not possible to predict some of the responses for string
fields. During the post pilot data collections phase some
of these variables have been coded. Using frequencies of
some of the data collected during this pilot phase, it has
been possible to provide selectable options for future
CABSYNC forms instead of open string fields. Data ana-
lysis was performed with Predictive Analytics Software
version 19.
Laboratory Methods
Blood culture
In order to determine the etiology of bacteremia, the
impact of prior antibiotic exposure on culture yield was
minimized by the use of the Bactec™ culture system
with culture bottles containing an antibiotic-removing
device (antibiotic resins). Bacteria were isolated from
blood using an automated blood-culture system (Bac-
tec™ 9050, Becton Dickinson, Temse, Belgium). The
study utilized only aerobic blood culture bottles. The
work-up for a positive culture vial included a subculture
using sheep blood agar or chocolate agar, both of which
were supplemented with micronutrients, e.g., iso-vitalex
or vitox, for enhanced growth of fastidious bacteria, or
McConkey agar plates. Inoculated media was incubated
under aerobic and 5% CO2 conditions at 35°C for 18-24
hours. Bacteria were identified by a combination of mor-
phology, Gram stain, and chemical methods; for S. pneu-
moniae, by susceptibility to ethyldrocupreine
hydrochloride (Optochin) and bile solubility; for H. influ-
enzae type b, X and V growth factor dependency detec-
tion and slide agglutination with type-specific antisera
(bioMerieux, France) and for Enterobacteriacae, we used
the API 20 E system (bioMerieux, France). Antibiotic
susceptibility assessments were determined by Kirby-
Buaer disc diffusion test using standard interpretative cri-
teria and using antibiotic discs for locally available anti-
biotics for the immediate management of patients.
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cultures were either obtained commercially from
(Remel) Fisher Scientific USA or when this was not
available, sheep blood was obtained from a local abat-
toir. Sheep blood was collected in to a citrate phosphate
donor bag and used for preparation of 5% blood agar
plates or chocolate agar plates, using previously
described methods for collection and defribrination [15].
Following primary identification of the bacteria isolates
at the study site lab, confirmation was sought at reference
laboratories. This service was provided by the Medical
Research Council Laboratories, The Gambia and Sparrow
Hospital Microbiology laboratory, an affiliate of Michigan
State University. Michigan State Department of Health
Laboratory confirmed the typing of the Salmonella species.
Bacteremia was defined as the isolation of at least one
non-contaminant bacteria from the admission blood cul-
ture. Coagulase-negative staphylococci, Bacillus, Coryne-
bacterium species or Micrococcoci were classified as
contaminants. S. viridians isolates were considered sig-
nificant when isolated from children with underlying
risk factors for S. viridians infection, such as congenital
heart defect.
Antimicrobial activity detection in serum
Micrococcus luteus-
ATCC 7468 (provided by the Centers for Disease Control
and Prevention, Atlanta) was grown overnight on agar
plate. Colonies from fresh culture plates were suspended
in normal saline, and calibrat e dt o0 . 5M c F a r l a n ds t a n -
dard. Using another cotton-tipped-sterile applicator, this
was inoculated on to a nutrient agar plate, streaking the
entire surface of the plate, rotating the plate 60°between
streaks and ultimately rimming the plate to ensure conflu-
ent growth to the edges. The inoculum was allowed to dry
for 5 minutes before depositing the 6-mm sterile paper fil-
ter discs. Using a sterile forceps 2 sterile discs were applied
~3 cm apart from each other, taking care not to remove
and replace any disc after it has been applied. Once all of
the above processes have been accomplished, add 20 μlo f
the test serum in one disc and 20 μl of sterile saline to the
other disc. A positive control disc of chloramphenicol was
used in each experiment. The inoculum was allowed to
dry and the plates inverted so that the media is on the
upper surface and cannot be contaminated by condensa-
tion. Plates were then incubated at 37°C in air atmosphere
for 18-24 hours before final reading. A ruler was used to
measure the zone of inhibition. Any inhibition zone bigger
than the saline disc (6 mm) was interpreted as positive for
previous antibiotic use.
Results
From September 2008 to November 2009, children who
presented with an acute febrile illness at the enrolling
facilities were screened and blood sample collected for
bacterial culture. 1,287 children were screened and
enrolled, of these 227 children were outside the age
range and 91 subjects had incomplete clinical data.
These were excluded from further analysis. Thus 969
children aged between 2 months -5 years with a median
age of 17 months (+/- 13.9 months) constitute the sub-
ject of this pilot report.
Bacteria was isolated from the blood stream of 204
children and of these, 93 were considered skin contami-
nants and not clinically relevant. Thus significant bacter-
emia occurred in 111/969 (11.5%) children.
The etiology of bacteremia is summarized in Figure 1.
Salmonella spp were the leading cause of bacteremia
(28.5%) with S.typhi predominating at 20.9% and non-
typhi salmonella (7.6%). S. aureus accounted for 20.9%
while Acinetobacter and S.pneumoniae accounted for
12.3% and 7.6% respectively. In five subjects alpha
hemolytic streptococcus was isolated and considered
clinically significant as these children had underlying
congenital cardiac disease.
Concordance between results from the site labora-
tory and the reference lab was 100% for non-typhi Sal-
monellae (NTS), Candida, Escherichia coli and
Pseudomonas. The concordance was lowest for alpha
hemolytic streptococcus as a number of these were
initially mis-identified as S. pneumoniae.T h ei d e n t i f i -
cation assigned by the reference laboratory was used
for final analysis.
The two Haemophilus influenzae isolates were not
recovered following primary storage and so we were
unable to type these organisms. Of the eight confirmed
S.pneumoniae isolates, three were 19F; two were 23F
and one each of serotypes 1, 5 and 6B.
Antimicrobial activity in serum
Approximately 10% of samples from each enrollment
site were randomly selected for testing. Prevalence of
serum antimicrobial activity was highest in children
who presented to the National Hospital (88.9%), the
major tertiary referral center in Abuja and was lowest
in those who presented to Zankli Medical Center
(40%) and Nyanya General Hospital (45%). Data sum-
marized in Figure 2.
In all, one hundred twenty six sera samples were
tested for antimicrobial activity (Table 1). Of these,
forty eight tested negative and seventy eight were posi-
tive. Of the samples that tested negative, forty six were
negative for bacterial growth and two tested positive
for bacterial growth (S. pneumoniae 1 and coagulase
negative staphylococcus). Of the samples that tested
positive for antimicrobial activity, eight had positive
bacterial culture (coagulase negative Staphylococcus 5,
E.coli 1, S.typhi -1 and S. pneumoniae-1).
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A variable number of bacterial isolates were available for
testing using different antibiotic discs. All S. aureus iso-
lates from the study were screened for methicillin resis-
tance and all were methicillin susceptible. However,
susceptibility varied among the spectrum of antibiotics.
Of thirteen isolates, all were susceptible to amoxicillin
and 20/20 were susceptible to Augmentin with the low-
est susceptibility rates seen with cefuroxime 4/12 (33%)
and septrin (cotrimoxazole) 12/21 (57%).
Of the S.typhi isolates susceptibility was highest
(100%) for ceftazidime, ceftriaxone, ciprofloxacin and
ofloxacin. Only 10/17 isolates were susceptible to amox-
icillin, 9/15 (53%) to augmentin and 11/19 to chloram-
phenicol. Susceptibility was lowest for septrin 10/21
(48%). S. pneumoniae isolates were highly susceptible
(100%) to augmentin, amoxycillin, clindamycin and
ceftriaxone. However, only three isolates were tested for
amoxicillin and clindamycin. S.pneumoniae isolates were
least susceptible to septrin.
Clinical Diagnosis and Bacteremia agent
Of the children with a bacteriologic diagnosis of S.aur-
eus bacteremia, 4/22 (17%) children presented with clin-
ical sepsis or bronchopneumonia and 2/22 (10%)
presented each with clinical diagnosis of febrile convul-
sion, acute gastroenteritis or pharyngotonsilitis. A large
proportion 10/22 (45%) were assigned a clinical diagno-
sis of malaria. In this setting all children who present
with an acute febrile illness are treated empirically for
malaria and we did not systematically examine blood
smears for malaria parasites. Children with S. typhi bac-
teremia were also most often assigned a clinical diagno-
sis of malaria 12/21 (55%) and sepsis in only 5/21 (24%)
 
969 enrolled and screened for 
bacteremia 
Gram Positive Bacteria 
S.aureus 22 (20.9%) 
S.pneumoniae 8 (7.6%) 
α- heamolytic Strep 5* 
(4.8%) 
Group B strep 1 (0.9%) 
Enterococcus 1 (0.9%) 
 
Gram Negative Bacteria 
S.typhi 22 (20.9%) 
Acinetobacter  spp 13 (12.3%) 
Non-typhi Salmonella 8 (7.6%) 
Klebsiella 6 (5.7%) 
E.coli 5 (4.8%) 
Pseudomonas 2 (1.9%) 
Enterobacter spp 2 (1.9%) 
Haemophilus influenzae 2 (1.9%) 
Burkholderia cepacia1 (0.9%) 
Flavobacterium spp 1 (0.9%) 
Chryseomonas luteola 1 (0.9%) 
Coliform Spp 1 (0.9%) 
Pantoea 1(0.9%) 
 
Contaminants 
Coagulase negative staphylococcus 63 
Diphtheroids 30 
Lactococcus 1 
Candida spp 3 (2.8%) 
Significant positive cultures 105 (10.8%) 
94 (9.7%)
1,287 screened 
227 Outside age range 
91 Incomplete data 
*Alpha heamolytic Strep isolated from children with underlying congenital heart disease,  
  thus considered clinically significant 
Figure 1 Summary of Etiologic Agents of Bacteremia in Children aged 2 months-5 years.
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was made in 2/6 (33%) of children who had pneumococ-
cal bacteremia and in both cases there was CSF pleocy-
tosis but CSF culture was negative. A clinical diagnosis
of malaria was made less often in these patients 2/13
(6%).
Underlying diagnosis
Underlying medical condition was ascertained by clinical
history in all participants (Table 2). There were fifty
nine children with a known diagnosis of sickle cell dis-
ease and thirty two with HIV-infection.
Of the children with SCD, 12/59 (20% had bacteremia
caused by a clinically significant pathogen). There were
three children with each of the following S.pneumoniae,
S.typhi and Acinetobacter, two children with NTS and
one with Pseudomonas spp.
There was no information available on clinical staging
or viral load data on HIV-infected children at the time
of presentation. Of the HIV-infected children 6/32 had
bacteremia caused by a clinically significant pathogen,
with S. aureus and S. pneumoniae in two children and
only one child had either E.coli or Klebsiella.
Deaths during hospitalization and phone follow-up
Our data collection system and personnel were inade-
quate for capturing all deaths following hospitalization.
However, we were able to capture deaths which
occurred typically less than 72 hrs after subject enroll-
ment, since laboratory culture results were usually made
available to the attending physicians within this time
frame. Fifteen deaths were recorded during this time
frame for a minimum case-fatality ratio of 1.5%. The
subject age, sex, initial clinical diagnosis and blood bac-
terial isolates are listed in Table 3.
At conclusion of the pilot phase of this study we
initiated a phone call to contact all study participant
parent/guardian of children who had a positive culture
at initial contact (1 mo-1 yr post enrollment). Of the
212 subjects with a positive culture including contami-
nants, we were able to reach 149 parents, 53 parents
were not reachable including 5 who had no phone num-
bers listed in the entry form. Of the parents that were
reachable, we were able to ascertain eight additional
deaths that had occurred after initial enrollment in this
study (total case-fatality of 2.4%). The subject age, sex,
initial clinical diagnosis and blood bacterial isolates are
listed in Table 4.
Discussion
This pilot study has demonstrated the public health sig-
nificance of etiologic diagnosis of acute febrile illness in
a setting where clinical malaria is over-diagnosed, non-
prescription antibiotics are prevalent and empiric pre-
scription antibiotic by physicians is the standard clinical
practice. This pilot study was sited at Abuja as it is the
federal capital city and it is strategically located for
access to both urban and rural populations.
The spectrum of agents of bacteremia from this pilot
study differs significantly from reports from the Gambia
Table 1 Antimicrobial Activity in Serum and Blood Culture Results
Bacterial Culture Result Negative Antimicrobial Activity Positive Antimicrobial Activity
Culture Negative 46 70
Culture Positive CNS*-1
S. pneumoniae-1
E.coli -1
CNS- 5
S.pneumoniae-1
S.typhi-1
CNS*- Coagulase negative Staphylococcus
Table 2 Distribution of Bacteria Isolate in Children with
Established Diagnosis of Sickle Cell Disease or Human
Immune Deficiency Virus (HIV) Infection
Bacteria Isolate Sickle Cell Disease (n = 59) HIV (n = 32)
S.aureus 02
S.pneumoniae 32
S.typhi 30
E.coli 01
NTS 2 0
Acinectobacter spp 3 0
Klebsiella 0 1
Pseudomonas 1 0
Contaminant 5 5
No Growth 42 21
Figure 2 Antimicrobial Activity in Serum by site of Enrolment.
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S. aureus and S. typhi were the leading cause. While in
the Gambia, the pneumococcus is the leading cause of
bacteremia and non-typhi salmonella is much more pre-
valent without any cases of S. typhi. The relatively less
significant role of pneumococcal bacteremia is likely to
be a significant epidemiologic finding secondary to the
high incidence of non-prescription antibiotic use. This is
most likely, given that all our pneumococcal isolates are
penicillin susceptible and the penicillins are the most
readily available oral antibiotics in this setting. It is unli-
kely that we missed clinical isolates, since we utilized a
culture system similar to that which was used in other
studies in Africa which have reported S. pneumoniae as
the leading cause of bacteremia in this age group. The
same explanation may also hold true for the scarcity of
H. influenzae from blood cultures. Although H. influen-
zae type b (Hib) vaccine is not included in the National
Immunization Program, it is often available in most
private hospitals and offered to those who can afford it.
However, it is not likely that it would be that widely
used to have impacted disease incidence in the wider
community. The relative burden of meningitis caused by
these two pathogens may be more significant. More
intense surveillance for meningitis is planned in the
next phase of this surveillance.
In a recent study from Ibadan [16] which utilized con-
ventional culture methods, of 24 cases of definite
meningitis 9 were caused by the pneumococcus and 11
by Hib only 4 were caused by Klebsiella spp; among
pneumonia cases 9 were caused by pneumococcus and
2 by Hib. Interestingly the bacteria isolates from bacter-
emia cases are similar to those in the current report. So
the spectrum of the bacteria recorded in the Abuja pro-
ject may be related to the prevalent disease spectrum.
Also a recent project undertaken just south of Ibadan
indicates high pneumococcal carriage rates (90%) in
young infants aged < 9 months. (Adetifa I and Adegbola
RA- personal communication). This is similar to the
carriage rates in The Gambian villages. There is no rea-
son to believe that in a well conducted population study
the pneumococcus and Hib may be as important in
Nigeria as in The Gambia or Kenya as causes of pneu-
monia and meningitis.
There may be a distinct difference in disease epide-
miology due to the multiple slum settlements on the
outskirt of Abuja which is more readily affordable to the
general population than Abuja city. Sanitary conditions
in these settlements are usually poor or non-existent.
The relatively high incidence of S.typhi is very concern-
ing and is an important public health issue. Currently,
no country in sub Saharan Africa implements routine
immunization with typhoid vaccine and reports from
several countries suggest that Non-typhi salmonella may
be a more important problem than S.typhi and there are
efforts towards developing vaccines for NTS, while the
currently available typhoid vaccines remain unused due
to lack of convincing disease burden evidence. Our pilot
data suggest that, at least in this setting there may well
be a need for implementing routine immunization with
typhoid vaccine. It is noteworthy that the current age
spectrum included in this study did not include school
age children 5-14 yrs, a subgroup that often has a higher
incidence of typhoid fever [17]; thus the observation in
our report is likely to be an underestimate.
Although S, pneumoniae did not feature as the leading
cause of bacteremia, it accounts for 13% of all the
deaths observed in this pilot study. The study from Iba-
dan [16] reported over 80% mortality with pneumococ-
cal meningitis in children and only in one study has
there been the observation of delayed mortality follow-
ing invasive pneumococal infection. Whether these
delayed deaths are associated with underlying conditions
Table 4 Additional Deaths Identified at Phone Follow-up
(1 month -1 yr after Enrolment)
ID Sex Age in Months Clinical Diagnosis Bacterial Isolate
43 M 3 Pneumonia NG
119 F 4 Gastroenteritis P.aerugionsa
435 M 60 Malaria NG
522 F 48 Pneumonia S.pneumoniae
525 M 14 SBE, CHD Flavobacterium
598 M 3 Pneumonia NG
772 M 6 Malaria, HIV Salmonella Spp
805 F 8 Sepsis, HIV S.pneumoniae
CHD-Congenital heart disease, SBE-Subacute bacterial endocarditis
Malaria diagnosis was based on clinical evaluation only
Table 3 Deaths at Hospital Discharge
ID Sex Age in Months Clinical Diagnosis Bacterial Isolate
63 F 2 Malaria NG
87 M 10 SCD, meningitis S.pneumoniae
310 F 4 Malaria NG
343 M 35 Malaria Salmonella Spp
351 F 4 Malaria, HIV NG
436 M 6 Malaria NG
562 F 5 CHD, Pneumonia NG
761 F 48 Sepsis, HIV H.influenzae
771 F 8 Malaria S.typhi
777 M 14 Malaria NG
790 M 7 Sepsis, CP Acinectobacter
813 M 57 Malaria NG
817 F 3 Malaria, HIV NG
973 M 48 Malaria NG
974 M 48 malaria NG
NG-No growth
Malaria diagnosis was based on clinical evaluation only
Obaro et al. BMC Infectious Diseases 2011, 11:137
http://www.biomedcentral.com/1471-2334/11/137
Page 8 of 10such as HIV, SCD or other immune defects have not
been formally investigated. Nigeria is yet to implement
routine immunization with the pneumococcal conjugate
vaccine. The limited number of invasive pneumococcal
isolates that were available from this pilot study suggests
that 75% of invasive pneumococcal disease may be pre-
ventable with the 7-valent and 100% with the new 13-
valent pneumococcal conjugate vaccine.
T h er a t eo fa n t i b i o t i cu s e ,a sd e m o n s t r a t e db yd e t e c -
tion of residual antimicrobial activity in serum, in the
community is high in most of the facilities and lowest at
ZMC, private hospital. The clientele at this facility are at
a higher socioeconomic status than those presenting to
the government facilities and are therefore more likely
to present early to a private health care provider. This is
an interesting observation that warrants further evalua-
tion since on a large scale this may well impact the pat-
tern of etiologic agents identified in children who
present to such a facility as opposed to Government
establishments. Future surveillance will incorporate
enrolment of children at private clinics that are staffed
by trained pediatricians.
We have in the course of this pilot study provided
increased awareness for physicians and health care pro-
viders on the need to carefully consider other diagnosis
in children who present with an acute febrile illness,
other than malaria and to seek etiologic diagnosis that
will properly guide management, particularly, given the
increasing reports of the decreasing incidence of malaria
in the sub region
18. We have also provided additional
laboratory skills for the identification of bacteria for
laboratory technicians and more importantly, we believe
providing this diagnostic service will improve the quality
of care and improve clinical outcome.
The etiologic agents and their susceptibility patterns
observed in this pilot study and other recent studies
raises concerns about the appropriateness of the current
treatment guidelines recommended by the Integrated
Management of Childhood Illness (IMCI). The first line
treatment for most conditions with co-trimoxazole or
the use of chloramphenicol for severe pneumonia
requires revision given the high prevalence of resistance
among the commonly isolated bacteria.
In setting up this pilot surveillance, we encountered a
number of challenges which are worth mentioning briefly
as these will inform the design of larger studies. First, we
observed a high contamination rate due largely to the fact
that physicians were not conversant with aseptic blood
draw techniques in young children and we also had a
rapid turnover of house physicians. Second, although
motivation of personnel to participate in the study was
initially strong, this waned over time as reflected in the
decreased enrolment rate at the different sites. Third, a
large number of the study questionnaire and patient sam-
pling for cerebrospinal fluid in suspected cases of meningi-
tis was incomplete. There was a general impression
amongst the clinical staff that this clinical research project,
while beneficial for patient management, increased their
workload. These obstacles will be overcome in future stu-
dies which will aim to have dedicated salaried personnel
for participant enrolment and obtaining relevant clinical
specimens. This study has several limitations. Three of the
most important include first, our inability to define a
population census from where our participants were
drawn and therefore unable to define incidence of bactere-
mia. While this was not the aim of this pilot study, clearly
incidence figures would be very useful. However, this
approach will be a challenge given the number of health-
care outlets available to the population. Second, we were
only able to evaluate the role of underlying conditions
such as SCD and HIV only in those who have an estab-
lished diagnosis. Ideally we should have tested all partici-
pants for this condition to determine the role of these
conditions in promoting the risk for specific bacteremia.
This approach is planned in the next phase of our surveil-
lance. Third, we were unable to provide systematic subject
enrollment and this could havei n t r o d u c e ds o m eb i a si n
sampling.
Conclusions
In conclusion, initial findings from the introduction of
an automatic blood culture system in Abuja suggest that
the spectrum of agents associated with community-
acquired bacteremia in young children in central Nigeria
may differ from that observed in most other African
countries with a predominance of S.typhi.T h i sm a yb e
due to environmental factors, antibiotic usage, patient
selection or technical factors, and epidemiological stu-
dies are urgently needed. While this may in part be due
to the multiple new settlements and satellite towns
around Abuja which in general have poor water supply
and sanitary facilities, there is also a high level of non-
prescription antibiotic use.
There is a need to intensify surveillance at both rural
and urban settlements, expand population surveillance
to include school age children and also to determine if
this pattern of infection is similar at other geographic
locations in the country. A detailed surveillance study
for the determination of the incidence of typhoid fever
is being planned. Such surveillance activities will be cri-
tical for informing the need for introduction of typhoid
fever vaccines in the medium term and improvement of
infrastructures in the long term. This expanded surveil-
lance should also provide additional data on the disease
burden caused by S. pneumoniae which appears cur-
rently confounded by widespread antibiotic use.
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